Edgar Filing: VioQuest Pharmaceuticals, Inc.

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

WEISER MICHAEL

2. Issuer Name and Ticker or Trading Symbol
VioQuest Pharmaceuticals, Inc. [VOQP]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

50 WEST 57TH STREET, 15TH FLOOR

3. Date of Earliest Transaction (Month/Day/Year)
06/13/2008

(Street)

NEW YORK, NY 10019

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.001 par value								161,206 ⁽¹⁾	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Warrant

$ 14.1 ⁽¹⁾

10/18/2005

10/18/2010

Common Stock, $.001 par value

28,000 ⁽¹⁾

Warrant

$ 4 ⁽¹⁾

06/29/2007

06/29/2012

Common Stock, $.001 par value

657 ⁽¹⁾

Series B Convertible Preferred Stock

$ 3.8 ⁽¹⁾

03/14/2008

⁽⁴⁾

Common Stock, $.001 par value

2,781 ⁽¹⁾

10.57

Stock Option

$ 19.6 ⁽¹⁾

06/13/2008

D⁽²⁾

1,290

⁽²⁾

10/28/2013

Common Stock, $.001 par value

1,290 ⁽¹⁾

$ 0

Stock Option

$ 0.54

06/13/2008

A⁽²⁾

1,290

⁽²⁾

10/28/2013

Common Stock, $.001 par value

1,290

$ 0

1,290

Stock Option

$ 3.8

06/13/2008

D⁽³⁾

10,000

⁽³⁾

07/11/2017

Common Stock, $.001 par value

10,000 ⁽¹⁾

$ 0

Stock Option

$ 0.54

06/13/2008

A⁽³⁾

10,000

⁽³⁾

07/11/2017

Common Stock, $.001 par value

10,000

$ 0

10,000

Stock Option

$ 0.54

06/13/2008

100,000

⁽⁵⁾

06/13/2018

Common Stock, $.001 par value

100,000

$ 0

100,000

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
WEISER MICHAEL 50 WEST 57TH STREET, 15TH FLOOR NEW YORK, NY 10019	X

Signatures

/s/ Michael Weiser		06/18/2008
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Adjusted to reflect a 1-for-10 reverse stock split effective on 4/25/2008.
(2)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 10/28/2003 and is fully vested.
(3)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 7/11/2007 and vests in three equal annual installments beginning on 7/11/2007.
(4)	No expiration date.
(5)	33,334 shares vest immediately, 33,333 shares vest on each of 6/13/2009 and 6/13/2010.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.